Novartis Misses Estimates as Vaccine Unit Slumps

Novartis Misses Estimates as Vaccine Unit Slumps Play

July 17 (Bloomberg) -- Novartis AG, the world’s largest drugmaker by revenue, reported second-quarter profit that missed analysts’ estimates, dragged down by declining sales and a worsening loss in the vaccine division it’s selling. Helvea Analyst Odile Rundquist speaks on “The Pulse.” (Source: Bloomberg)

  • On Air Now

    Charlie Rose Watch Now

  • Next

    Bloomberg West

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus